These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2589004)

  • 1. Acetylcholine receptor antibody in myasthenia gravis.
    Marchiori PE; dos Reis M; Quevedo ME; Scaff M; Cossermelli W; Assis JL; de Oliveira RM
    Acta Neurol Scand; 1989 Nov; 80(5):387-9. PubMed ID: 2589004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features of patients with Myasthenia gravis from the Henan province, China.
    Gao F; Zhao X; Zhang J; Cui X; Zhang Y; Li Q; Liu P; Fang H; Du Y; Zhang Q; Yang J; Zhang Y
    Muscle Nerve; 2016 May; 53(5):711-6. PubMed ID: 26403759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in myasthenia gravis.
    Havard CW
    Br Med J; 1977 Oct; 2(6093):1008-11. PubMed ID: 336138
    [No Abstract]   [Full Text] [Related]  

  • 4. In myasthenia gravis, clinical and immunological improvement post-thymectomy segregate with results of in vitro antibody secretion by immunocytes.
    Katzberg HD; Aziz T; Oger J
    J Neurol Sci; 2002 Oct; 202(1-2):77-83. PubMed ID: 12220697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myasthenia gravis (second of two parts).
    Drachman DB
    N Engl J Med; 1978 Jan; 298(4):186-93. PubMed ID: 339085
    [No Abstract]   [Full Text] [Related]  

  • 6. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
    Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
    Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of thymectomy and serum acetylcholine receptor antibodies in myasthenia gravis.
    Olanow CW; Wechsler AS; Roses AD
    Ann Surg; 1982 Aug; 196(2):113-21. PubMed ID: 7092360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunopathology of acetylcholine receptors in myasthenia gravis.
    Seybold ME; Lindstrom JM
    Springer Semin Immunopathol; 1982; 5(4):389-412. PubMed ID: 6761884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis.
    Howard JF; Bril V; Burns TM; Mantegazza R; Bilinska M; Szczudlik A; Beydoun S; Garrido FJRR; Piehl F; Rottoli M; Van Damme P; Vu T; Evoli A; Freimer M; Mozaffar T; Ward ES; Dreier T; Ulrichts P; Verschueren K; Guglietta A; de Haard H; Leupin N; Verschuuren JJGM;
    Neurology; 2019 Jun; 92(23):e2661-e2673. PubMed ID: 31118245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myasthenia gravis: the unmet needs of a paradigmatic autoimmune disease.
    Modrego PJ
    Neurodegener Dis Manag; 2018 Jun; 8(3):137-139. PubMed ID: 29943694
    [No Abstract]   [Full Text] [Related]  

  • 11. Scientific overview of myasthenia gravis and an assessment of the role of plasmapheresis.
    Tindall RS
    Prog Clin Biol Res; 1982; 106():113-42. PubMed ID: 6757936
    [No Abstract]   [Full Text] [Related]  

  • 12. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
    Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D
    Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 3. The effect of thymectomy.
    Oosterhuis HJ; Limburg PC; Hummel-Tappel E; Van den Burg W; The TH
    J Neurol Sci; 1985 Jul; 69(3):335-43. PubMed ID: 4031948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylcholine receptor antibodies in myasthenia gravis.
    Kornfeld P; Nall J; Smith H; Mittag TW; Bender AN; Ambinder EP; Horowitz SH; Papatestas AE; Gross H; Genkins G
    Muscle Nerve; 1981; 4(5):413-9. PubMed ID: 6974823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between acetylcholine receptor antibody levels and thymic pathology in myasthenia gravis: a review.
    Huang GZ; Lo YL
    J Clin Neuromuscul Dis; 2013 Jun; 14(4):209-17. PubMed ID: 23703018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunology of myasthenia gravis.
    Biesecker G; Koffler D
    Hum Pathol; 1983 May; 14(5):419-23. PubMed ID: 6840752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational therapy of myasthenia gravis.
    Finley JC; Pascuzzi RM
    Semin Neurol; 1990 Mar; 10(1):70-82. PubMed ID: 2189183
    [No Abstract]   [Full Text] [Related]  

  • 18. Acetylcholine receptor autoantibody secretion by thymocytes: relationship to myasthenia gravis.
    Yoshikawa H; Lennon VA
    Neurology; 1997 Aug; 49(2):562-7. PubMed ID: 9270597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunopathogenesis and treatment of myasthenia gravis.
    Levinson AI; Zweiman B; Lisak RP
    J Clin Immunol; 1987 May; 7(3):187-97. PubMed ID: 3036906
    [No Abstract]   [Full Text] [Related]  

  • 20. In myasthenia gravis cells from atrophic thymus secrete acetylcholine receptor antibodies.
    Katzberg HD; Aziz T; Oger J
    Neurology; 2001 Feb; 56(4):572-3. PubMed ID: 11222815
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.